{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:01:03Z","timestamp":1786546863304,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04392-6","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:59:04Z","timestamp":1779361144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNA-563 as a potential biomarker in triple-negative breast cancer: impeding tumor progression by targeting ITGAV and epithelial-mesenchymal transition"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaobo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"4392_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2021.0459","volume":"83","author":"C Katsura","year":"2022","unstructured":"Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Breast cancer: presentation, investigation and management. Br J Hosp Med (Lond). 2022;83:1\u20137.","journal-title":"Br J Hosp Med (Lond)"},{"key":"4392_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, Huang L, Liu CC, Shao ZM, Yu KD. Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther. 2025;10:49.","journal-title":"Signal Transduct Target Ther"},{"key":"4392_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of Triple-Negative Breast Cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"key":"4392_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","volume":"22","author":"L Yin","year":"2020","unstructured":"Yin L, Duan JJ, Bian XW, Yu SC. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020;22:61.","journal-title":"Breast Cancer Res"},{"key":"4392_CR5","doi-asserted-by":"publisher","first-page":"115545","DOI":"10.1016\/j.bcp.2023.115545","volume":"212","author":"AM Karim","year":"2023","unstructured":"Karim AM, Eun Kwon J, Ali T, Jang J, Ullah I, Lee YG, Park DW, Park J, Jeang JW, Kang SC. Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies. Biochem Pharmacol. 2023;212:115545.","journal-title":"Biochem Pharmacol"},{"key":"4392_CR6","doi-asserted-by":"publisher","first-page":"e230034","DOI":"10.1148\/rg.230034","volume":"43","author":"BE Adrada","year":"2023","unstructured":"Adrada BE, Moseley TW, Kapoor MM, Scoggins ME, Patel MM, Perez F, Nia ES, Khazai L, Arribas E, Rauch GM, Guirguis MS. Triple-Negative Breast Cancer: Histopathologic Features, Genomics, and Treatment. Radiographics. 2023;43:e230034.","journal-title":"Radiographics"},{"key":"4392_CR7","doi-asserted-by":"crossref","unstructured":"Ferrari P, Scatena C, Ghilli M, Bargagna I, Lorenzini G, Nicolini A. Molecular mechanisms, biomarkers and emerging therapies for chemotherapy resistant TNBC. Int J Mol Sci. 2022;23:1665.","DOI":"10.3390\/ijms23031665"},{"key":"4392_CR8","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234:5451\u201365.","journal-title":"J Cell Physiol"},{"key":"4392_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-3-031-08356-3_9","volume":"1385","author":"M Hill","year":"2022","unstructured":"Hill M, Tran N. miRNA:miRNA Interactions: A Novel Mode of miRNA Regulation and Its Effect On Disease. Adv Exp Med Biol. 2022;1385:241\u201357.","journal-title":"Adv Exp Med Biol"},{"key":"4392_CR10","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s12015-023-10510-8","volume":"19","author":"MR Kalhori","year":"2023","unstructured":"Kalhori MR, Soleimani M, Alibakhshi R, Kalhori AA, Mohamadi P, Azreh R, Farzaei MH. The Potential of miR-21 in Stem Cell Differentiation and its Application in Tissue Engineering and Regenerative Medicine. Stem Cell Rev Rep. 2023;19:1232\u201351.","journal-title":"Stem Cell Rev Rep"},{"key":"4392_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4274\/tjh.galenos.2022.2022.0054","volume":"39","author":"X Fu","year":"2022","unstructured":"Fu X, He Y, Song J, Wang L, Guo P, Cao J. MiRNA-181b-5p Modulates Cell Proliferation, Cell Cycle, and Apoptosis by Targeting SSX2IP in Acute Lymphoblastic Leukemia. Turk J Haematol. 2022;39:160\u20139.","journal-title":"Turk J Haematol"},{"key":"4392_CR12","first-page":"111798","volume":"825","author":"J Luo","year":"2022","unstructured":"Luo J, Xia L, Zhang L, Zhao K, Li C. MiRNA-144-5p down-modulates CDCA3 to regulate proliferation and apoptosis of lung adenocarcinoma cells. Mutat Res. 2022;825:111798.","journal-title":"Mutat Res"},{"key":"4392_CR13","doi-asserted-by":"publisher","first-page":"e16033","DOI":"10.15252\/emmm.202216033","volume":"15","author":"R Dinami","year":"2023","unstructured":"Dinami R, Pompili L, Petti E, Porru M, D\u2019Angelo C, Di Vito S, Rizzo A, Campani V, De Rosa G, Bruna A, et al. MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer. EMBO Mol Med. 2023;15:e16033.","journal-title":"EMBO Mol Med"},{"key":"4392_CR14","doi-asserted-by":"publisher","first-page":"154400","DOI":"10.1016\/j.prp.2023.154400","volume":"244","author":"H Yan","year":"2023","unstructured":"Yan H, Huang W, Chen C, Zhang X, Zhu K, Yuan J. MiR-133a\/CD47 axis is a novel prognostic biomarker to promote triple negative breast cancer progression. Pathol Res Pract. 2023;244:154400.","journal-title":"Pathol Res Pract"},{"key":"4392_CR15","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s12033-022-00491-3","volume":"64","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S, Nath D. A Study on microRNAs Targeting the Genes Overexpressed in Lung Cancer and their Codon Usage Patterns. Mol Biotechnol. 2022;64:1095\u2013119.","journal-title":"Mol Biotechnol"},{"key":"4392_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15:129.","journal-title":"J Hematol Oncol"},{"key":"4392_CR17","doi-asserted-by":"publisher","first-page":"6141857","DOI":"10.1155\/2022\/6141857","volume":"2022","author":"W Gao","year":"2022","unstructured":"Gao W, Yang N, Yin C, Zeng Y, Zhu X. Engineered Exosomes Loaded with miR-563 Inhibit Lung Cancer Growth. J Oncol. 2022;2022:6141857.","journal-title":"J Oncol"},{"key":"4392_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/1759-7714.13257","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang X, Li M, Sun G, Bai Y, Lv D, Liu C. MiR-563 restrains cell proliferation via targeting LIN28B in human lung cancer. Thorac Cancer. 2020;11:55\u201361.","journal-title":"Thorac Cancer"},{"key":"4392_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000528670","volume":"90","author":"I Endo","year":"2023","unstructured":"Endo I, Amatya VJ, Kushitani K, Nakagiri T, Aoe K, Takeshima Y. miR-142-3p Suppresses Invasion and Adhesion of Mesothelioma Cells by Downregulating ITGAV. Pathobiology. 2023;90:270\u201380.","journal-title":"Pathobiology"},{"key":"4392_CR20","doi-asserted-by":"publisher","first-page":"1480771","DOI":"10.3389\/fimmu.2025.1480771","volume":"16","author":"X Shi","year":"2025","unstructured":"Shi X, Zang J, Gu Q, Zhang M, Sun H, Yang L, Cheng J, Wang R, Mao H, Xu A, et al. Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancer progression and immune infiltration. Front Immunol. 2025;16:1480771.","journal-title":"Front Immunol"},{"key":"4392_CR21","doi-asserted-by":"publisher","first-page":"152531","DOI":"10.1016\/j.prp.2019.152531","volume":"215","author":"H Wang","year":"2019","unstructured":"Wang H, Chen H, Jiang Z, Lin Y, Wang X, Xiang J, Peng J. Integrin subunit alpha V promotes growth, migration, and invasion of gastric cancer cells. Pathol Res Pract. 2019;215:152531.","journal-title":"Pathol Res Pract"},{"key":"4392_CR22","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/curroncol31030099","volume":"31","author":"L Xu","year":"2024","unstructured":"Xu L, Barrett JG, Peng J, Li S, Messadi D, Hu S. ITGAV Promotes the Progression of Head and Neck Squamous Cell Carcinoma. Curr Oncol. 2024;31:1311\u201322.","journal-title":"Curr Oncol"},{"key":"4392_CR23","first-page":"211","volume":"10","author":"IW Cheuk","year":"2020","unstructured":"Cheuk IW, Siu MT, Ho JC, Chen J, Shin VY, Kwong A. ITGAV targeting as a therapeutic approach for treatment of metastatic breast cancer. Am J Cancer Res. 2020;10:211\u201323.","journal-title":"Am J Cancer Res"},{"key":"4392_CR24","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1111\/cas.15532","volume":"113","author":"M Chen","year":"2022","unstructured":"Chen M, Wu C, Fu Z, Liu S. ICAM1 promotes bone metastasis via integrin-mediated TGF-beta\/EMT signaling in triple-negative breast cancer. Cancer Sci. 2022;113:3751\u201365.","journal-title":"Cancer Sci"},{"key":"4392_CR25","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/iej.14229","volume":"58","author":"J Zeng","year":"2025","unstructured":"Zeng J, Yang Y, Jiang C, Wu B, Chen M. An HRL-SC\/HIF-1alpha positive feedback loop enhances cell proliferation, migration and angiogenesis in dental pulp stem cells via PI3K\/AKT signalling pathway. Int Endod J. 2025;58:1006\u201324.","journal-title":"Int Endod J"},{"key":"4392_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12943-024-01944-w","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang C, Yu Z, Yang S, Liu Y, Song J, Mao J, Li M, Zhao Y. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK\/PI3K\/AKT activation in a ceRNA manner. Mol Cancer. 2024;23:33.","journal-title":"Mol Cancer"},{"key":"4392_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12964-019-0464-x","volume":"17","author":"XX Zuo","year":"2019","unstructured":"Zuo XX, Yang Y, Zhang Y, Zhang ZG, Wang XF, Shi YG. Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin alpha2beta1-contacting-mediated activation of Wnt-beta-catenin pathway. Cell Commun Signal. 2019;17:142.","journal-title":"Cell Commun Signal"},{"key":"4392_CR28","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.21873\/anticanres.17665","volume":"45","author":"HJ Shim","year":"2025","unstructured":"Shim HJ, Park MS, Bae WK, Cho SH, Chung IJ, Kim DH. ITGAV Regulation of LGALS3BP-JUNB Axis Facilitates the Cell-to-Cell Adhesion and Invasiveness of Hepatic Cancer Cells. Anticancer Res. 2025;45:2997\u20133008.","journal-title":"Anticancer Res"},{"key":"4392_CR29","doi-asserted-by":"publisher","first-page":"102097","DOI":"10.1016\/j.canep.2022.102097","volume":"77","author":"T Thi Chung Duong","year":"2022","unstructured":"Thi Chung Duong T, Nguyen THN, Thi Ngoc Nguyen T, Huynh LH, Ngo HP, Thi Nguyen H. Diagnostic and prognostic value of miR-200 family in breast cancer: A meta-analysis and systematic review. Cancer Epidemiol. 2022;77:102097.","journal-title":"Cancer Epidemiol"},{"key":"4392_CR30","doi-asserted-by":"crossref","unstructured":"Martini S, Zuco V, Tortoreto M, Percio S, Campi E, El Bezawy R, Doldi V, Landesman Y, Pennati M, Zaffaroni N. miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer. Pharmaceuticals (Basel). 2021;14:523.","DOI":"10.3390\/ph14060523"},{"key":"4392_CR31","doi-asserted-by":"publisher","first-page":"657547","DOI":"10.3389\/fcell.2021.657547","volume":"9","author":"Z Huang","year":"2021","unstructured":"Huang Z, Pan J, Wang H, Du X, Xu Y, Wang Z, Chen D. Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer. Front Cell Dev Biol. 2021;9:657547.","journal-title":"Front Cell Dev Biol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04392-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:03:50Z","timestamp":1786543430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04392-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4392"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04392-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of Ningbo Yinzhou No.2 Hospital approved the study, and all enrolled patients provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"331"}}